Form 8-K Sana Biotechnology, Inc. For: Sep 06

Go back to Form 8-K Sana Biotechnology, Inc. For: Sep 06

Sana Biotechnology (SANA) Announces CFO Resignation

September 12, 2024 4:41 PM EDT

On September 6, 2024, Nathan Hardy notified Sana Biotechnology (NASDAQ: SANA) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024. Mr. Hardy resigned voluntarily for personal reasons and not as a result of... More